Description
EPOFIT 4000 IU Injection (INTAS) is a recombinant human erythropoietin (epoetin alfa) used to treat anemia caused by chronic kidney disease, chemotherapy, or certain antiretroviral therapies. It works by stimulating the bone marrow to increase red blood cell production, thereby improving oxygen delivery throughout the body.
Each dose contains 4000 IU of epoetin alfa and is administered either subcutaneously or intravenously, depending on clinical need and physician guidance. EPOFIT helps reduce the need for blood transfusions and supports improved energy and quality of life in patients with symptomatic anemia.
Manufactured by INTAS Pharmaceuticals, EPOFIT is produced under stringent quality standards to ensure safety, efficacy, and consistent dosing.
Important: Use only under the supervision of a qualified healthcare provider. Routine monitoring of hemoglobin levels and iron status is essential during treatment.
Reviews
There are no reviews yet.